AOP Orphan Pharmaceuticals Announces Progress of Pivotal Phase III Trial PROUD-PV of Novel Mono-Pegylated Interferon Alpha 2b for the Treatment of Polycythemia Vera
. - AOP Orphan announces progress of pan-European phase III trial PROUD-PV to support European Marketing Authorization…